Disease | cardiomyopathy |
Phenotype | C0006142|breast cancer |
Sentences | 2 |
PubMedID- 23741376 | Clinical studies have suggested no beneficial effect of metoprolol, a β1-ar blocker, in dox-treated lymphoma patients [15] but a beneficial effect of nebivolol, a β1-ar blocker associated to a β3-ar agonistic properties against anthracycline-induced cardiomyopathy in patients with breast cancer [55]. |
PubMedID- 21555361 | Anthracycline-induced cardiomyopathy in siblings with early breast cancer. |
Page: 1